2.7082
price down icon0.00%   -0.0018
 
loading
Schlusskurs vom Vortag:
$2.71
Offen:
$2.725
24-Stunden-Volumen:
1.00M
Relative Volume:
0.34
Marktkapitalisierung:
$386.50M
Einnahmen:
$4.21M
Nettoeinkommen (Verlust:
$-97.67M
KGV:
-2.912
EPS:
-0.93
Netto-Cashflow:
$-70.76M
1W Leistung:
-2.87%
1M Leistung:
-0.37%
6M Leistung:
-2.17%
1J Leistung:
-11.15%
1-Tages-Spanne:
Value
$2.67
$2.748
1-Wochen-Bereich:
Value
$2.64
$2.86
52-Wochen-Spanne:
Value
$2.01
$6.33

Absci Corp Stock (ABSI) Company Profile

Name
Firmenname
Absci Corp
Name
Telefon
(360) 949-1041
Name
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Name
Mitarbeiter
157
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-18
Name
Neueste SEC-Einreichungen
Name
ABSI's Discussions on Twitter

Vergleichen Sie ABSI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ABSI
Absci Corp
2.709 386.50M 4.21M -97.67M -70.76M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.87 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
528.08 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
319.68 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.99 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
240.49 28.51B 3.81B -644.79M -669.77M -6.24

Absci Corp Stock (ABSI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-22 Eingeleitet Needham Buy
2024-10-02 Eingeleitet Guggenheim Buy
2024-07-03 Eingeleitet Morgan Stanley Overweight
2024-03-14 Eingeleitet Scotiabank Sector Outperform
2023-12-05 Eingeleitet KeyBanc Capital Markets Overweight
2023-05-04 Eingeleitet H.C. Wainwright Buy
2022-08-12 Herabstufung JP Morgan Overweight → Underweight
2022-07-18 Eingeleitet Truist Buy
2022-03-02 Fortgesetzt Cowen Market Perform
2022-02-01 Eingeleitet Berenberg Buy
2021-11-10 Herabstufung BofA Securities Neutral → Underperform
2021-10-15 Fortgesetzt Cowen Market Perform
2021-08-16 Eingeleitet BofA Securities Neutral
2021-08-16 Eingeleitet Cowen Market Perform
2021-08-16 Eingeleitet Credit Suisse Outperform
2021-08-16 Eingeleitet Stifel Hold
Alle ansehen

Absci Corp Aktie (ABSI) Neueste Nachrichten

pulisher
Jun 17, 2025

Millennium Management LLC Sells 1,149,603 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat

Jun 17, 2025
pulisher
Jun 16, 2025

Absci Co. (NASDAQ:ABSI) Given Average Rating of "Buy" by Brokerages - MarketBeat

Jun 16, 2025
pulisher
Jun 09, 2025

Transcript : Absci Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - marketscreener.com

Jun 09, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Raises Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Purchases 28,073 Shares of Absci Co. (NASDAQ:ABSI) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Absci (NASDAQ:ABSI) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Jun 02, 2025
pulisher
Jun 01, 2025

Top 5 AI & Digital Biotech Companies (June 2025) - Securities.io

Jun 01, 2025
pulisher
Jun 01, 2025

Absci (NASDAQ:ABSI) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 28, 2025

AbSci Corp (ABSI) Sees Borrow Rate Increase | ABSI Stock News - GuruFocus

May 28, 2025
pulisher
May 27, 2025

Woodline Partners LP Decreases Position in Absci Co. (NASDAQ:ABSI) - MarketBeat

May 27, 2025
pulisher
May 27, 2025

Northern Trust Corp Has $1.72 Million Stock Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 27, 2025
pulisher
May 27, 2025

Brokerages Set Absci Co. (NASDAQ:ABSI) Price Target at $8.40 - MarketBeat

May 27, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Absci (NASDAQ:ABSI) to Hold - Defense World

May 24, 2025
pulisher
May 23, 2025

Ameriprise Financial Inc. Sells 23,668 Shares of Absci Co. (NASDAQ:ABSI) - Defense World

May 23, 2025
pulisher
May 22, 2025

AbSci Corp (ABSI): Key Indicator Shows Noticeable Increase | ABSI Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Catherine Wood's Strategic Acquisition of Absci Corp Shares - GuruFocus

May 21, 2025
pulisher
May 20, 2025

Schonfeld Strategic Advisors LLC Has $144,000 Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Absci to Participate in Upcoming Investor Conferences - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

Absci Sets Stage for Major AI Breakthroughs at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Needham & Company LLC Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 19, 2025
pulisher
May 17, 2025

Absci Co. (NASDAQ:ABSI) Shares Sold by Stifel Financial Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Absci (NASDAQ:ABSI) - Defense World

May 16, 2025
pulisher
May 15, 2025

Absci Corp’s Earnings Call: A Promising Outlook - TipRanks

May 15, 2025
pulisher
May 15, 2025

Absci Corporation (NASDAQ:ABSI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

Absci First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Acquires 241,779 Shares of Absci Co. (NASDAQ:ABSI) - Defense World

May 15, 2025
pulisher
May 14, 2025

ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Absci (ABSI) Initiates Phase 1 Study of AI-Designed Antibody ABS-101 | ABSI Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Absci (ABSI) Launches First Human Trial for ABS-101 - GuruFocus

May 14, 2025
pulisher
May 14, 2025

ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI S - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Assessing Absci: Insights From 6 Financial Analysts - Benzinga

May 14, 2025
pulisher
May 14, 2025

Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga

May 14, 2025
pulisher
May 14, 2025

Absci Corporation Advances Clinical Programs with Strong Q1 Results - TipRanks

May 14, 2025
pulisher
May 14, 2025

Fred Alger Management LLC Reduces Position in Absci Co. (NASDAQ:ABSI) - MarketBeat

May 14, 2025
pulisher
May 13, 2025

Absci Corp Q1 2025 Earnings: EPS Beats Estimates at -$0.21, Reve - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Absci earnings beat by $0.01, revenue fell short of estimates - Investing.com

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Absci Q1 2025 sees stock surge post-earnings By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

AbSci (ABSI) Anticipates Significant Post-Earnings Movement | AB - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Absci Q1 2025 sees stock surge post-earnings - Investing.com

May 13, 2025
pulisher
May 13, 2025

Absci Q1 2025 Earnings Call Transcript - MarketBeat

May 13, 2025
pulisher
May 13, 2025

Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Absci Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

ABSI Surprises with Q1 Revenue Beat and Expands Clinical Initiat - GuruFocus

May 13, 2025
pulisher
May 13, 2025

ABSI Surprises with Q1 Revenue Beat and Expands Clinical Initiatives | ABSI Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Absci reports first participants dosed in Phase 1 ABS-101 trial - TipRanks

May 13, 2025
pulisher
May 13, 2025

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Absci Announces First Participants Dosed In Phase 1 Clinical Trial Of Abs-101, A Potential Best-In-Class Anti-TL1a Antibody For The Treatment Of Inflammatory Bowel Disease - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Breakthrough: First-Ever AI-Designed IBD Treatment Begins Human Trials with Quarterly Dosing Potential - Stock Titan

May 13, 2025
pulisher
May 12, 2025

What To Expect From Absci Corp (ABSI) Q1 2025 Earnings - GuruFocus

May 12, 2025

Finanzdaten der Absci Corp-Aktie (ABSI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Kapitalisierung:     |  Volumen (24h):